{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T20:49:44Z","timestamp":1791924584495,"version":"4.3.4"},"reference-count":41,"publisher":"Informa UK Limited","issue":"9","license":[{"start":{"date-parts":[[2023,4,28]],"date-time":"2023-04-28T00:00:00Z","timestamp":1682640000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Pharmacotherapy"],"published-print":{"date-parts":[[2023,6,13]]},"DOI":"10.1080\/14656566.2023.2206015","type":"journal-article","created":{"date-parts":[[2023,4,28]],"date-time":"2023-04-28T12:04:03Z","timestamp":1682683443000},"page":"1013-1020","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":26,"title":["Recent advances in treating hypertriglyceridemia in patients at high risk of cardiovascular disease with apolipoprotein C-III inhibitors"],"prefix":"10.1080","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9953-4923","authenticated-orcid":false,"given":"Catherine M","family":"Spagnuolo","sequence":"first","affiliation":[{"name":"Depatment of Medicine, Schulich School of Medicine and Dentistry, Western University, London, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2861-5325","authenticated-orcid":false,"given":"Robert A","family":"Hegele","sequence":"additional","affiliation":[{"name":"Depatment of Medicine, Schulich School of Medicine and Dentistry, Western University, London, Ontario, Canada"},{"name":"Vascular Biology Research Group, Robarts Research Institute, London, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2023,4,28]]},"reference":[{"key":"cit0001","doi-asserted-by":"publisher","DOI":"10.1080\/14779072.2021.1955348"},{"key":"cit0002","doi-asserted-by":"publisher","DOI":"10.17925\/EE.2022.18.2.82"},{"key":"cit0003","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehab551"},{"key":"cit0004","doi-asserted-by":"publisher","DOI":"10.1080\/14656566.2019.1594776"},{"key":"cit0005","doi-asserted-by":"publisher","DOI":"10.1517\/14656566.2015.1041504"},{"key":"cit0006","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2018.04.054"},{"key":"cit0007","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.118.313238"},{"key":"cit0008","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2004215"},{"key":"cit0009","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2007.03.003"},{"key":"cit0010","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2007.03.002"},{"key":"cit0011","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2210645"},{"key":"cit0012","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)67667-2"},{"key":"cit0013","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(06)69594-9"},{"key":"cit0014","doi-asserted-by":"publisher","DOI":"10.1001\/jamacardio.2016.4828"},{"key":"cit0015","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.22258"},{"key":"cit0016","doi-asserted-by":"publisher","DOI":"10.1001\/jamacardio.2021.1157"},{"key":"cit0017","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1812792"},{"key":"cit0018","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2022.11.008"},{"key":"cit0019","unstructured":"Respect-EPA: highly purified EPA appears to reduce risks of CV events in Japanese CAD patients on statins. American College of Cardiology. Chicago IL: American Heart Association Scientific Sessions, 2022.[Last accessed 2023 Jan 22] Available at: https:\/\/www.acc.org\/latest-in-cardiology\/articles\/2022\/11\/01\/22\/00\/sun-7pm-respect-epa-aha-2022"},{"key":"cit0020","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.113.301464"},{"key":"cit0021","doi-asserted-by":"publisher","DOI":"10.1097\/MOL.0000000000000502"},{"key":"cit0022","doi-asserted-by":"publisher","DOI":"10.1126\/science.1161524"},{"key":"cit0023","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCGENETICS.113.000369"},{"key":"cit0024","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1308027"},{"key":"cit0025","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1307095"},{"key":"cit0026","doi-asserted-by":"publisher","DOI":"10.1038\/nature22034"},{"key":"cit0027","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.118.311476"},{"key":"cit0028","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.160607"},{"key":"cit0029","doi-asserted-by":"publisher","DOI":"10.1172\/JCI86610"},{"key":"cit0030","doi-asserted-by":"publisher","DOI":"10.1194\/jlr.M093740"},{"key":"cit0031","doi-asserted-by":"publisher","DOI":"10.1172\/JCI127308"},{"key":"cit0032","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1400284"},{"key":"cit0033","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1400283"},{"key":"cit0034","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacl.2022.06.005"},{"key":"cit0035","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehab820"},{"key":"cit0036","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1715944"},{"key":"cit0037","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(21)00046-2"},{"key":"cit0038","doi-asserted-by":"publisher","DOI":"10.2337\/dc16-0126"},{"key":"cit0039","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehaa689"},{"key":"cit0040","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.122.059266"},{"key":"cit0041","unstructured":"Pfizer and Ionis announce discontinuation of vupanorsen clinical development program. News release. Ionis Pharmaceuticals, Inc, 2022. [Last accessed 2023 Jan 22]. Available at: https:\/\/www.prnewswire.com\/news-releases\/pfizer-and-ionis-announce-discontinuation-of-vupanorsen-clinical-development-program-301471041.html"}],"container-title":["Expert Opinion on Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14656566.2023.2206015","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,30]],"date-time":"2023-05-30T10:09:46Z","timestamp":1685441386000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14656566.2023.2206015"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,28]]},"references-count":41,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023,6,13]]}},"alternative-id":["10.1080\/14656566.2023.2206015"],"URL":"https:\/\/doi.org\/10.1080\/14656566.2023.2206015","relation":{},"ISSN":["1465-6566","1744-7666"],"issn-type":[{"value":"1465-6566","type":"print"},{"value":"1744-7666","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,28]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieop20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieop20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2023-02-17","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-04-19","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-04-28","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}